These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17408249)

  • 1. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
    Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
    J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
    D'Amico DC; Aya T; Human J; Fotsch C; Chen JJ; Biswas K; Riahi B; Norman MH; Willoughby CA; Hungate R; Reider PJ; Biddlecome G; Lester-Zeiner D; Staden CV; Johnson E; Kamassah A; Arik L; Wang J; Viswanadhan VN; Groneberg RD; Zhan J; Suzuki H; Toro A; Mareska DA; Clarke DE; Harvey DM; Burgess LE; Laird ER; Askew B; Ng G
    J Med Chem; 2007 Feb; 50(4):607-10. PubMed ID: 17243660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
    Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl sulfonamides containing tetralin allylic amines as potent and selective bradykinin B1 receptor antagonists.
    Liu Q; Qian W; Li A; Biswas K; Chen JJ; Fotsch C; Han N; Yuan C; Arik L; Biddlecome G; Johnson E; Kumar G; Lester-Zeiner D; Ng GY; Hungate RW; Askew BC
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4593-7. PubMed ID: 20573508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
    Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
    Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of potent, orally bioavailable phthalazinone bradykinin B1 receptor antagonists.
    Biswas K; Peterkin TA; Bryan MC; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    J Med Chem; 2011 Oct; 54(20):7232-46. PubMed ID: 21902230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Oxo-2-piperazinyl acetamides as potent bradykinin B1 receptor antagonists for the treatment of pain and inflammation.
    Chen JJ; Nguyen T; D'Amico DC; Qian W; Human J; Aya T; Biswas K; Fotsch C; Han N; Liu Q; Nishimura N; Peterkin TA; Yang K; Zhu J; Riahi BB; Hungate RW; Andersen NG; Colyer JT; Faul MM; Kamassah A; Wang J; Jona J; Kumar G; Johnson E; Askew BC
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3384-9. PubMed ID: 21514825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SSR240612 [(2R)-2-[((3R)-3-(1,3-benzodioxol-5-yl)-3-[[(6-methoxy-2-naphthyl)sulfonyl]amino]propanoyl)amino]-3-(4-[[2R,6S)-2,6-dimethylpiperidinyl]methyl]phenyl)-N-isopropyl-N-methylpropanamide hydrochloride], a new nonpeptide antagonist of the bradykinin B1 receptor: biochemical and pharmacological characterization.
    Gougat J; Ferrari B; Sarran L; Planchenault C; Poncelet M; Maruani J; Alonso R; Cudennec A; Croci T; Guagnini F; Urban-Szabo K; Martinolle JP; Soubrié P; Finance O; Le Fur G
    J Pharmacol Exp Ther; 2004 May; 309(2):661-9. PubMed ID: 14747609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
    Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
    J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
    Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
    J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonamido-aryl ethers as bradykinin B1 receptor antagonists.
    Cole AG; Metzger A; Brescia MR; Qin LY; Appell KC; Brain CT; Hallett A; Ganju P; Denholm AA; Wareing JR; Ritchie TJ; Drake GM; Bevan SJ; MacGloinn A; McBryde A; Patel V; Oakley PJ; Nunez X; Gstach H; Schneider P; Baldwin JJ; Dolle RE; McDonald E; Henderson I
    Bioorg Med Chem Lett; 2009 Jan; 19(1):119-22. PubMed ID: 19014884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-hydroxy amides as a novel class of bradykinin B1 selective antagonists.
    Wood MR; Schirripa KM; Kim JJ; Kuduk SD; Chang RK; Di Marco CN; DiPardo RM; Wan BL; Murphy KL; Ransom RW; Chang RS; Holahan MA; Cook JJ; Lemaire W; Mosser SD; Bednar RA; Tang C; Prueksaritanont T; Wallace AA; Mei Q; Yu J; Bohn DL; Clayton FC; Adarayn ED; Sitko GR; Leonard YM; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2008 Jan; 18(2):716-20. PubMed ID: 18061443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzodiazepines as potent and selective bradykinin B1 antagonists.
    Wood MR; Kim JJ; Han W; Dorsey BD; Homnick CF; DiPardo RM; Kuduk SD; MacNeil T; Murphy KL; Lis EV; Ransom RW; Stump GL; Lynch JJ; O'Malley SS; Miller PJ; Chen TB; Harrell CM; Chang RS; Sandhu P; Ellis JD; Bondiskey PJ; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2003 May; 46(10):1803-6. PubMed ID: 12723943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromenones as potent bradykinin B1 antagonists.
    Bryan MC; Biswas K; Peterkin TA; Rzasa RM; Arik L; Lehto SG; Sun H; Hsieh FY; Xu C; Fremeau RT; Allen JR
    Bioorg Med Chem Lett; 2012 Jan; 22(1):619-22. PubMed ID: 22088753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.